Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Executives - The Untold Story

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT. Mark Singleton, Bioventus’ senior vice president and chief financi

MarketBeat

Celsius Plots Energy Drink Comeback as Alani, Rockstar Deals Reshape Growth

Celsius (NASDAQ:CELH) executives said the company is working through a major portfolio transition as it integrates Alani and Rockstar into its platform while repositioning the core Celsius brand for renewed growth. Speaking at an investor conference, Chairman and CEO John Fieldly described the comp

MarketBeat

Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH Trial

Altimmune (NASDAQ:ALT) executives said the company is preparing to begin enrolling patients in the second half of the year for a Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, while also awaiting data from related alcohol-associated liver disease programs.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach

Ardelyx (NASDAQ:ARDX) executives said at the Jefferies Global Healthcare Conference that the company is focused on expanding demand for its commercial products, IBSRELA and XPHOZAH, while continuing to invest in its pipeline and positioning the business for sustainable profitability. Chief Financia

MarketBeat

ALX Oncology Targets Key Readouts to Advance CD47, EGFR Cancer Drug Programs

ALX Oncology (NASDAQ:ALXO) executives said the company is focused on advancing two clinical-stage oncology programs, with upcoming data readouts expected to shape potential later-stage development plans for its lead CD47 program, evorpacept, and its EGFR-targeted antibody-drug conjugate, ALX2004. S

MarketBeat

Brilliant Earth Group Bets on Fine Jewelry and Showrooms to Spark Growth

Brilliant Earth Group (NASDAQ:BRLT) executives outlined the jewelry company’s brand, retail and growth strategy during a hosted discussion featuring Chief Executive Officer Beth Gerstein and Chief Brand Officer Pamela Catlett. The company, described in the event as a digitally native jeweler focuse

MarketBeat

AvePoint Conference: AI Governance Push Fuels AgentPulse Pipeline

AvePoint (NASDAQ:AVPT) executives said the company is broadening its position from its Microsoft roots into a wider data management, governance and AI security platform, with artificial intelligence driving new customer conversations and pipeline growth. Speaking at a Jefferies event hosted by anal

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Modine Manufacturing Q4 Earnings Call Highlights

Modine Manufacturing (NYSE:MOD) executives said the company closed fiscal 2026 with another record year for revenue and adjusted EBITDA, driven by rapid growth in data center cooling and the continuing reshaping of its portfolio toward higher-growth businesses. President and Chief Executive Officer

MarketBeat

Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus

Karyopharm Therapeutics (NASDAQ:KPTI) executives said the company expects to provide a fuller presentation of its Phase 3 SENTRY trial data for selinexor in myelofibrosis at the upcoming ASCO conference, while also outlining expected regulatory engagement and other development priorities during a re

MarketBeat

Flexsteel Industries Sees Outsized Growth as Margins Rise, Buybacks Cut Share Count

Flexsteel Industries (NASDAQ:FLXS) executives outlined the furniture manufacturer’s growth strategy, margin outlook and capital allocation priorities during a company presentation, emphasizing recent share gains despite a weak industry backdrop. President and CEO Derek Schmidt said the company has

MarketBeat

Flex Pitches AI Data Center Spin-Off as Power and Cooling Growth Accelerates

Flex (NASDAQ:FLEX) executives used a J.P. Morgan fireside chat to outline the rationale for the company’s latest planned spin-off, describe the growth expectations for the business being separated and frame the remaining Flex as a large, diversified manufacturing and services platform. Revathi Adva

MarketBeat

Booz Allen Hamilton Q4 Earnings Call Highlights

Booz Allen Hamilton (NYSE:BAH) executives said the government technology contractor exited what Chief Executive Horacio Rozanski called its “most challenging year” as a public company with stronger profitability than expected, even as revenue declined because of weakness in its civil business. On t

MarketBeat

Lightspeed Commerce Q4 Earnings Call Highlights

Lightspeed Commerce (NYSE:LSPD) executives said the company’s fiscal fourth quarter capped a “pivotal” year in which its narrower focus on North American retail and European hospitality drove stronger growth, improved profitability and a more streamlined operating model following the divestiture of

MarketBeat

Walmart Q1 Earnings Call Highlights

Walmart (NASDAQ:WMT) executives said the retailer delivered stronger-than-expected first-quarter fiscal 2027 sales growth, driven by higher transactions, e-commerce momentum, marketplace gains and growth in advertising and membership revenue, while higher fuel costs weighed on operating income. CEO

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Gogoro Q1 Earnings Call Highlights

Gogoro (NASDAQ:GGR) executives said the company began 2026 with improved margins, positive operating cash flow and continued growth in its battery-swapping subscriber base, while outlining plans for new scooter launches, network upgrades and a Vietnam pilot. On the company’s first-quarter earnings

MarketBeat

CDW Touts AI Factory Demand, Recurring Revenue Push at JPMorgan Conference

CDW (NASDAQ:CDW) executives said customers are moving beyond artificial intelligence experimentation and are increasingly asking for help deploying AI “safely, economically, and at scale,” during a JPMorgan fireside chat featuring Chair and CEO Christine Leahy and CFO Albert Miralles. Leahy said th

MarketBeat

Toll Brothers Q2 Earnings Call Highlights

Toll Brothers (NYSE:TOL) executives said the luxury homebuilder delivered better-than-expected fiscal second-quarter results despite a challenging demand environment, prompting the company to raise its full-year guidance across key homebuilding metrics. Executive Chairman Doug Yearley said the comp

MarketBeat

Roivant Sciences Q4 Earnings Call Highlights

Roivant Sciences (NASDAQ:ROIV) executives used the company’s fourth-quarter earnings call to highlight new open-label data for IMVT-1402 in difficult-to-treat rheumatoid arthritis, upcoming pulmonary hypertension data for mosliciguat and continued preparation for a potential brepocitinib launch in d

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data

Aura Biosciences (NASDAQ:AURA) executives outlined the company’s strategy for its lead candidate bel-sar during a session at the H.C. Wainwright Connect Conference, emphasizing ocular oncology as the company’s initial development focus while also discussing ongoing work in non-muscle invasive bladde

MarketBeat

AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth

AirSculpt Technologies (NASDAQ:AIRS) executives said the body contouring company has returned to same-store sales growth after more than two years of declines, while outlining plans to expand services tied to GLP-1 weight-loss drug side effects and eventually resume clinic growth across the U.S. Ch

MarketBeat

Green Plains Touts Operational Gains, Carbon Capture Upside at Conference

Green Plains (NASDAQ:GPRE) executives said the company’s recent performance has been driven by tighter operating discipline, a simplified business structure and new opportunities tied to carbon capture and federal biofuels incentives. Speaking at a company event, Chief Financial Officer Ann Reis sa

MarketBeat

Fiserv Investor Day Sets AI, Clover Roadmap to Revive Growth and Top $12 EPS

Fiserv (NASDAQ:FISV) executives used the company’s 2026 Investor Day to outline a medium-term plan aimed at restoring what CEO Mike Lyons described as Fiserv’s historical identity as a “constant compounder,” while acknowledging recent service, product delivery and client retention challenges. Lyons

MarketBeat

Under Armour Q4 Earnings Call Highlights

Under Armour (NYSE:UA) executives said the athletic apparel company is entering fiscal 2027 with a sharper focus on premium products, disciplined inventory management and marketing efficiency after a fiscal 2026 marked by revenue declines, tariff pressure and a continued business reset. On the comp

MarketBeat

Appian Pitches Reliable AI, $825M Revenue Goal and Bigger Buyback at Investor Day

Appian (NASDAQ:APPN) executives used the company’s Investor Day 2026 in New York to frame the software maker as a provider of “complex process automation” for regulated industries and as a platform for making artificial intelligence more reliable in enterprise workflows. Chief Financial Officer Ser

MarketBeat

Bullish Q1 Earnings Call Highlights

Bullish (NYSE:BLSH) executives used the company’s first-quarter 2026 earnings call to frame its planned acquisition of Equiniti Group as a major strategic shift toward tokenized securities, while also reporting year-over-year revenue and profitability gains despite weaker digital asset prices. Chai

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.